Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2005
10/13/2005WO2005095459A2 Monoclonal antibodies to gastrin hormone
10/13/2005WO2005095458A1 CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
10/13/2005WO2005095457A2 Immunoglobulins
10/13/2005WO2005095456A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/13/2005WO2005095455A1 Antibody specific for parafibromin, a new marker of parathyroid carcinoma
10/13/2005WO2005095454A1 Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk
10/13/2005WO2005095453A2 Specific binding members against synaptophysin
10/13/2005WO2005094900A1 Preventive and/or remedy for cancer
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094883A2 Methods for inducing autolysis in infectious bacteria
10/13/2005WO2005094882A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094880A1 Method for treating autoimmune diseases with antibodies
10/13/2005WO2005094879A2 Monoclonal antibodies specific for human ox40l (cd 134l)
10/13/2005WO2005094876A1 Diagnostics and therapeutics for diseases associated with p21 (cdkn1a)-activated kinase 2 (pak2)
10/13/2005WO2005094846A1 Remedy for prion disease and method of producing the same
10/13/2005WO2005094572A1 Nonhuman animal for constructing antibody and method and system of constructing antibody using the same
10/13/2005WO2005094446A2 Anti-myostatin antibodies
10/13/2005WO2005094391A2 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN
10/13/2005WO2005094364A2 Iga antibody protein as a cytotoxic drug
10/13/2005WO2005094356A2 Cngh0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
10/13/2005WO2005094355A2 Methods for altering protein production rates
10/13/2005WO2005094348A2 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer
10/13/2005WO2005094338A2 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
10/13/2005WO2005094159A2 Methods of identifying neoplasm-specific antibodies and uses thereof
10/13/2005WO2005079766A3 Therapeutic combination comprising a tissue factor antagonist and anti-cancer compounds
10/13/2005WO2005069717A3 The use os anti-rh antibodies for treating acute thrombocytopenia associated with dengue hemorrhagic fever, hepatitis c and other microbial infections
10/13/2005WO2005067648A3 Multiplex spatial profiling of gene expression
10/13/2005WO2005065328A3 Macrophage migration inhibitory factor (mif) as marker for urological inflammatory disease
10/13/2005WO2005063290A3 Use of il-18 binding protein in inflammations
10/13/2005WO2005062972A3 Treatment of cancer with novel anti-il 13 monoclonal antibodies
10/13/2005WO2005058352A3 Treatment of rheumatoid arthritis with galectin-3 antagonists
10/13/2005WO2005037313A3 Tissue repair by modulation of beta-1 integrin biological function
10/13/2005WO2005035558A3 Piscirickettsia salmonis antigens and use thereof
10/13/2005WO2005014654A3 Product comprising a c4bp core protein and a monomeric antigen, and its use
10/13/2005WO2005010205A3 Biomarkers fo aggrecanase activity
10/13/2005WO2005005638A3 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18
10/13/2005WO2004067570A3 Prostate cancer diagnosis and treatment
10/13/2005WO2004062578A3 Methods for reducing mortality associated with acute myocardial infarction
10/13/2005WO2003099779A3 Hemipteran muscarinic receptor
10/13/2005WO2003088808A3 Compositions and methods for the diagnosis and treatment of tumor
10/13/2005WO2002014467A9 Cng2b: a putative human cyclic nucleotide-gated ion channel
10/13/2005US20050229275 Production of biomedical peptides and proteins in plants using plant virus vectors
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050227351 Methods and compound protein molecules used for inducing cytotoxic cell-mediated immune response in a mammal against a pathogenic cell
10/13/2005US20050227328 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/13/2005US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment
10/13/2005US20050227317 Mammalian expression system
10/13/2005US20050227303 Method and composition for diagnosis of melanocytic lesions
10/13/2005US20050227292 Allergenic protein complex of natural rubber latex
10/13/2005US20050227289 Antibodies to erythropoietin receptor and uses thereof
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227280 Proteases
10/13/2005US20050227279 Methods of using torsin proteins, to prevent protein misfolding and treat protein aggregation-associated disorders
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050226889 Inhibition of viral infection and spread with viral and RhoA-derived peptides
10/13/2005US20050226886 Preferential detection of procarboxypeptidase R (thrombin activatable fibrinolyisis inhibitor) by enzyme-linked immunosorbent assay
10/13/2005US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
10/13/2005US20050226884 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
10/13/2005US20050226883 Humanized antibody
10/13/2005US20050226882 Method and multicomponent conjugates for treating cancer
10/13/2005US20050226880 Use of a preparation based on an antibody directed against a tumor-associated glycosylation
10/13/2005US20050226879 Methods and compositions related to inhibiting nuclear envelope breakdown
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226876 Anti-P-selectin antibodies
10/13/2005US20050226875 Uses of anti-CTLA-4 antibodies
10/13/2005US20050226874 Point mutations; immunology
10/13/2005US20050226873 Medical devices and methods for modulating cell adhesion
10/13/2005US20050226872 Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract
10/13/2005US20050226870 Administering anti-inflammatory amount of a purified antibody specific against C5, wherein antibody inhibits the cleavage of C5 into C5a and C5b
10/13/2005US20050226869 inhibiting the growth of a cell that expresses a protein of the invention; antitumor agents; identify polypeptides, cell membrane-associated, secreted or intracellular polypeptides whose expression is specifically limited to only a single (or very limited number of different) tissue type(s)
10/13/2005US20050226868 Method for treating tumors using anti-osteopontin antibodies
10/13/2005US20050226867 Immunoglobulin specific to interleukin receptor-5 (IL-R) for preventing and treating allergic disorders; immunotherapy
10/13/2005US20050226866 Bone morphogenic protein specific immunoglobulin for treatment of bone diseases; immunotherapy
10/13/2005US20050226865 Methods and compositions for treating and preventing diseases associated with alphavbeta5 integrin
10/13/2005US20050226864 Alteration of Fc-fusion protein serum half-lives by mutagenesis
10/13/2005US20050226863 Single-domain antibodies and uses thereof
10/13/2005US20050226862 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders and for identifying agents therapeutic therefor
10/13/2005US20050226861 Immunogen adherence inhibitor and method of making and using same
10/13/2005US20050226812 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005CA2584608A1 Specific binding members against synaptophysin
10/13/2005CA2565175A1 Cancer diagnosis and treatment using anti-robo1 antibody
10/13/2005CA2563117A1 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor
10/13/2005CA2563024A1 Method for treating autoimmune diseases with antibodies
10/13/2005CA2562953A1 Humanized and chimeric anti-osm antibodies
10/13/2005CA2562038A1 Methods and compositions for treating and preventing disease associated with .alpha.v.beta.5 integrin
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2561702A1 Methods for altering protein production rates
10/13/2005CA2561405A1 Monoclonal antibodies to gastrin hormone
10/13/2005CA2561111A1 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
10/13/2005CA2560889A1 Monoclonal antibodies specific for human ox40l (cd 134l)
10/13/2005CA2560782A1 Methods and compositions for the detection of cervical disease
10/13/2005CA2560011A1 Cospeptin, cosmedin and their uses
10/13/2005CA2558435A1 Methods for inducing autolysis in infectious bacteria
10/13/2005CA2557843A1 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase
10/13/2005CA2545512A1 Methods of identifying neoplasm-specific antibodies and uses thereof
1 ... 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 ... 1494